A Study to Evaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control
Clinical trial NCT03242018 · COMPLETED
Trial details
- NCT number
- NCT03242018
- Sponsor
- Lexicon Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-16
- Primary completion
- 2019-05-16
- Enrollment
- 277
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.